- Home
- SURG vs LTRN Comparison
SURG vs LTRN Comparison
Compare SURG & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- LTRN
- Stock Information
- Founded
- SURG 2006
- LTRN 2013
- Country
- SURG United States
- LTRN United States
- Employees
- SURG N/A
- LTRN N/A
- Industry
- SURG Advertising
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- LTRN Health Care
- Exchange
- SURG Nasdaq
- LTRN Nasdaq
- Market Cap
- SURG 56.5M
- LTRN 36.0M
- IPO Year
- SURG N/A
- LTRN 2020
- Fundamental
- Price
- SURG $3.18
- LTRN $3.74
- Analyst Decision
- SURG Strong Buy
- LTRN Strong Buy
- Analyst Count
- SURG 1
- LTRN 1
- Target Price
- SURG $9.00
- LTRN $25.00
- AVG Volume (30 Days)
- SURG 90.4K
- LTRN 283.8K
- Earning Date
- SURG 08-12-2025
- LTRN 08-07-2025
- Dividend Yield
- SURG N/A
- LTRN N/A
- EPS Growth
- SURG N/A
- LTRN N/A
- EPS
- SURG N/A
- LTRN N/A
- Revenue
- SURG $40,029,467.00
- LTRN N/A
- Revenue This Year
- SURG $57.76
- LTRN N/A
- Revenue Next Year
- SURG $112.61
- LTRN N/A
- P/E Ratio
- SURG N/A
- LTRN N/A
- Revenue Growth
- SURG N/A
- LTRN N/A
- 52 Week Low
- SURG $1.05
- LTRN $2.55
- 52 Week High
- SURG $3.47
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- SURG 62.14
- LTRN 63.62
- Support Level
- SURG $3.28
- LTRN $3.21
- Resistance Level
- SURG $3.34
- LTRN $3.75
- Average True Range (ATR)
- SURG 0.24
- LTRN 0.24
- MACD
- SURG 0.04
- LTRN 0.07
- Stochastic Oscillator
- SURG 90.12
- LTRN 98.65
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.